Anti-acetycholine receptor antibodies in penicillamine treated patients without myasthenia gravis

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.

Journal of neuroimmunology·2005

Antibodies associated with paraneoplastic neurological disorders.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2005

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Journal of neurology, neurosurgery, and psychiatry·2005

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.

Neurology·2005

FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.

Acta neurologica Scandinavica·2005

Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms.

Journal of clinical pharmacy and therapeutics·2005

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Titanium Hypersensitivity as a Potential Contributor to Bronchopleural Fistula and Surgical Staple Extrusion Following Lung Cancer Surgery: A Case Report.

Case reports in pulmonology·2026

Prophylactic Soraphen A Treatment Attenuates Western Diet-Exacerbated IMQ-Induced Psoriasiform Inflammation.

European journal of immunology·2026

Diagnostic performance and clinical utility of open oral food challenges using double-blind, placebo-controlled food challenges as the reference standard: A systematic review.

Allergology international : official journal of the Japanese Society of Allergology·2026

Refining atopic dermatitis pathogenesis: Early-life trajectories, noncanonical cytokines, and JAK-STAT signaling.

The Journal of allergy and clinical immunology·2026

Local Microenvironment in Adenoid Hypertrophy and Its Clinical Relevance.

Current medical science·2026

Practical protocols and clinical experience from an academically based oral immunotherapy program.

Current opinion in pediatrics·2026

Related Experiment Videos

Anti-acetycholine receptor antibodies in penicillamine treated patients without myasthenia gravis

Related Concept Videos

Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes.

Antibodies associated with paraneoplastic neurological disorders.

Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis.

Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia.

FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology.

Grapefruit juice-nifedipine interaction: possible involvement of several mechanisms.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Titanium Hypersensitivity as a Potential Contributor to Bronchopleural Fistula and Surgical Staple Extrusion Following Lung Cancer Surgery: A Case Report.

Prophylactic Soraphen A Treatment Attenuates Western Diet-Exacerbated IMQ-Induced Psoriasiform Inflammation.

Diagnostic performance and clinical utility of open oral food challenges using double-blind, placebo-controlled food challenges as the reference standard: A systematic review.

Refining atopic dermatitis pathogenesis: Early-life trajectories, noncanonical cytokines, and JAK-STAT signaling.

Local Microenvironment in Adenoid Hypertrophy and Its Clinical Relevance.

Practical protocols and clinical experience from an academically based oral immunotherapy program.

Related Experiment Videos

Anti-acetycholine receptor antibodies in penicillamine treated patients without myasthenia gravis

Related Concept Videos

Related Articles